| Literature DB >> 35055135 |
Vadim Ershov1, Natalia Tarasova2, Evgeny Abkhalimov1, Alexey Safonov1, Vladimir Sorokin3, Boris Ershov1.
Abstract
The great attention paid to silver nanoparticles is largely related to their antibacterial and antiviral effects and their possible use as efficient biocidal agents. Silver nanoparticles are being widely introduced into various areas of life, including industry, medicine, and agriculture. This leads to their spreading and entering the environment, which generates the potential risk of toxic effect on humans and other biological organisms. Proposed paper describes the preparation of silver hydrosols containing spherical metal nanoparticles by photochemical reduction of Ag+ ions with oxalate ions. In deaerated solutions, this gives ~10 nm particles, while in aerated solutions, ~20 nm particles with inclusion of the oxide Ag2O are obtained. Nanoparticles inhibit the bacterium Escherichia coli and suppress the cell growth at concentrations of ~1 × 10-6-1 × 10-4 mol L-1. Silver particles cause the loss of pili and deformation and destruction of cell membranes. A mechanism of antibacterial action was proposed, taking into account indirect suppressing action of Ag+ ions released upon the oxidative metal dissolution and direct (contact) action of nanoparticles on bacterial cells, resulting in a change in the shape and destruction of the bacteria.Entities:
Keywords: antibacterial; dissolution; nanoparticles; oxygen stress; reactive oxygen species; toxicity
Mesh:
Substances:
Year: 2022 PMID: 35055135 PMCID: PMC8780126 DOI: 10.3390/ijms23020949
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1TEM and DLS images of silver nanoparticles and particle-size-distribution histograms. Solution: [Ag+] = 3 × 10−4 mol L−1; [C2O42−] = 5 × 10−4 mol L−1; (a,c,e) deaerated; (b,d,f) in air. pH = 7.0 ± 0.1.
Figure 2Diffraction pattern of Ag (a) and Ag2O-Ag (b) nanoparticles and comparison of the intensity of electron diffraction reflexes and JCPDS data (c), respectively.
Figure 3Absorbance of silver nanoparticles obtained in deaerated (Ag-NPs) and in aerated (Ag-Ag2O-NPs) solutions.
Characteristics of silver nanoparticles.
| Nanoparticle | Hydrosol Stability, | |||||
|---|---|---|---|---|---|---|
| Ag-NP | 386 | 35 | 10.1 ± 2.8 | 12.3 ± 2.5 | −68.3 | 2–3 |
| Ag-Ag2O-NP | 408 | 86 | 22.3 ± 4.2 | 24.1 ± 4.0 | −67.4 | >6 |
Figure 4Absorption spectra of silver hydrosol (a) Ag-NPs and (b) Ag-Ag2O-NPs in modified liquid culture medium “Adkins M”.
Figure 5DLS diagrams of silver hydrosol Ag-Ag2O-NPs (20 nm) in liquid culture medium “Adkins M”.
Figure 6Quantity of cells: result of inhibition by various concentrations of silver.
Antibacterial characteristics of Ag+ and nanoparticles against Escherichia coli cells.
| Type | Size, nm | Surface Functionalization | Effect | Medium | Reference |
|---|---|---|---|---|---|
| Ag+ | - | - | MIC = 0.3 mg L−1, | Adkins M | This work |
| Ag-Ag2O nanoparticles | 22 ± 3 | Carbonate | MIC = 11 mg L−1, | Adkins M | This work |
| Ag nanoparticles | 10 ± 2 | Carbonate | MIC = 5.4 mg L−1, | Adkins M | This work |
| AgCl nanoparticles | 250 | Unfunctionalized | 0.5 mg L−1 inhibits bacterial growth by 66 ± 6% | BBL™ containing 5 g/L Gelysate™ peptone and 3 g/L beef extract, pH = 6.9 ± 0.2 | [ |
| Ag nanoparticles | 14–16 | PVA | 0.5 mg L−1 inhibits bacterial growth by 55 ± 8% | BBL™ containing 5 g/L Gelysate™ peptone and 3 g/L beef extract, pH = 6.9 ± 0.2 | [ |
| Ag+ | - | - | 0.5 mg L−1 inhibits bacterial growth by 100% | BBL™ containing 5 g/L Gelysate™ peptone and 3 g/L beef extract, pH = 6.9 ± 0.2 | [ |
| Ag nanoparticles (octahedral) | 194 ± 50 | PVP | MIC = 50 mg L−1 | LB medium | [ |
| Ag nanoparticles (spherical) | 195 ± 50 | Citrate | MIC not achieved, IC50 = 1000 mg L−1 | LB medium | [ |
| Ag nanoparticles | 7 | Gallic acid | MIC = 6.25 mg L−1 | Mueller–Hinton broth | [ |
| Ag nanoparticles | 29 | Gallic acid | MIC = 13.02 mg L−1 | Mueller–Hinton broth | [ |
| Ag nanoparticles | 89 | Gallic acid | MIC = 11.79 mg L−1 | Mueller–Hinton broth | [ |
| Ag nanoparticles | 12.2 | Citrate | MIC = 13.8 mg L−1 | Cation-adjusted Mueller–Hinton broth (CA-MHB) | [ |
| Ag nanoparticles | 10.2 ± 2.3 | Citrate | IC50 = 5 mg L−1 | 2 mM NaHCO3 | [ |
| Ag nanoparticles | 10.2 ± 2.3 | Citrate | IC50 = 5 mg L−1 | 2 mM NaHCO3 | [ |
| Ag nanoparticles | 9.9 ± 2.0 | Mercaptopropionic sulfonic acid | MIC = 15 mg L−1 | 2 mM NaHCO3 | [ |
| Ag nanoparticles | 16.6 (6.5–43.8) | Not reported | IC50 = 1.56 mg L−1 | DMEM supplemented with l-glutamine (4 mM), penicillin (100 units/mL), streptomycin (100 μg/mL) and 10% ( | [ |
| Ag nanoparticles | 10 | Citrate | 30 mg L−1 inhibit bacterial growth; | LB medium | [ |
| Ag2S nanoparticles | 9 ± 3.5 | Unfunctionalized | Not toxic at 150 mg L−1 | RPMI medium supplemented with 0.2 mM l-glutamine, 100 μg mL−1 penicillin, 100 μg mL−1 streptomycin and 10% FBS | [ |
| Ag+ | - | - | MIC = 3.5 mg L−1 for 103 cells; | LB medium | [ |
| Ag+ | - | - | MIC = 0.5–1 mg L−1 for 103 cells, | RPMI/FCS | [ |
| Ag nanoparticles | 75 ± 20 | PVP | MBC = 12.5–20 mg L−1 for 103 cells | RPMI/FCS | [ |
| Ag nanoparticles | 11.3 (3–40) | Laser ablation | MIC = 110 ± 16 mg L−1 (microdillution assay); | Nutritionally impoverished LB (5.0 g of tryptone, 2.5 g of yeast extract, and 5.0 g of NaCl per 1 L) | [ |
| AgCl nanoparticles | 3 | Unfunctionalized | MIC = 2 mg L−1 | LB | [ |
| Ag nanoparticles | 10.8 ± 4.2 | Bis-2-ethylhexyl sulfosuccinate (AOT) | MBC = 0.3 mg L−1 | LB (solid, with agar) | [ |
| Ag nanoparticles | 10.8 ± 4.3 | Cetyltrimethyl-ammonium bromide (CTAB) | MBC = 0.2 mg L−1 | LB (solid, with agar) | [ |
| Ag nanoparticles | 13.5 ± 7.1 | Poly-L-lysine (PLL) | MBC = 0.2 mg L−1 | LB (solid, with agar) | [ |
| Ag nanoparticles | 15.2 ± 6.9 | Polysorbate 80 (Tween 80) | MBC = 0.5 mg L−1 | LB (solid, with agar) | [ |
| Ag+ | - | - | IC50 = 7 mg L−1 12 h) | LB medium containing ampicillin (100 μg mL−1) | [ |
| Ag nanoparticles | 39.5 ± 10.7 | PVP | IC50 = 4 mg L−1 12 h) | LB medium containing ampicillin (100 μg mL−1) | [ |
| Ag nanoparticles | 4.65 ± 0.5 | Citrate | MIC = 5.59 mg L−1 | LB | [ |
| Ag nanoparticles | 38.5 | PVP | MIC = 700 mg L−1 | DMEM containing 10% fetal calf serum and 1% penicillin G-streptomycin | [ |
Figure 7Photomicrograph of Escherichia coli, control.
Figure 8Photomicrographs of Escherichia coli grown in the presence of silver ions (1 × 10−5 mol L−1).
Figure 9Photomicrographs of Escherichia coli grown in the presence of Ag-Ag2O-NPs (20 nm) (1 × 10−5 mol L−1).
Figure 10EDS spectrum of Escherichia coli cells: control (a); exposure with silver ions Ag+ (1 × 10−5 mol L−1) (b); exposure with Ag-Ag2O-NPs (1 × 10−5 mol L−1) (c).